Skip to main content
Article
Licensed
Unlicensed Requires Authentication

Pulmonary function in children with type 1 diabetes mellitus

  • EMAIL logo , , , , and
Published/Copyright: August 7, 2014
Journal of Pediatric Endocrinology and Metabolism
From the journal Journal of Pediatric Endocrinology and Metabolism Volume 28 Issue 1-2

Abstract

Aim: To assess lung function in children and adolescents with type 1 diabetes mellitus (T1DM).

Patients and methods: We conducted a case-control study of 100 patients with T1DM [median age 13 (10.6–14.7), 44% men, 23% prepubertal, and all nonsmokers] and 77 controls. None had evidence of lung disease or any other comorbidity. We performed pulmonary function tests, including spirometry [forced vital capacity (FVC), forced expiratory volume in 1 s (FEV1), and FEV1/FVC ratio], plethysmography [total lung capacity (TLC), residual volume (RV), RV/TLC ratio, and airway resistance (Raw)], and diffusing capacity of carbon monoxide in the lung (TLCO), alveolar volume (AV), and TLCO/AV ratio. The duration of diabetes, degree of metabolic control, insulin dose, and presence of diabetic complications were registered. The χ2-test and analysis of variance were used to compare categorical and quantitative variables, respectively.

Results: The duration of diabetes was 6.2±3.8 years with a median HbA1c of 7.08±0.4%. FEV1/FVC ratio was found to be significantly higher in patients with TIDM than in controls. Patients with diabetes also had a nonsignificant trend towards lower FVC, FEV1, Raw, and TLCO, and higher RV, TLC, and RV/TLC than controls. There were no differences in pulmonary function based on duration of disease or metabolic control. We found differences in pulmonary evaluation when pubertal stage was analyzed.

Conclusions: The lung is functionally involved in children with T1DM. Pubertal development stage influences the evaluation of lung function.

Keywords: adolescent; children; pulmonary function; type 1 diabetes mellitus
Corresponding author: María Martín-Frías, MD, Pediatric Diabetes and Endocrinology Unit, Hospital Universitario Ramón y Cajal, Carretera Colmenar, Km 9.1, 28034 Madrid, Spain, Phone: +34 913368646, Fax: +34 913368417, E-mail:

References

1. Karvonen M, Viik-Kajander M, Moltchanova E, Libman I, LaPorte R, et al. Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care 2000;23:1516–26.10.2337/diacare.23.10.1516Search in Google Scholar

2. The Diabetes Control and Complications Trial Research Group. Effect of the intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus. J Pediatr 1994;125:177–88.10.1016/S0022-3476(94)70190-3Search in Google Scholar

3. The Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group. Beneficial effects on intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT). J Pediatr 2001;139:804–12.10.1067/mpd.2001.118887Search in Google Scholar

4. Rask-Madsen C, He Z, King GL. Mechanism of diabetic microvascular complications. In: Kahn CR, Weis GC, King GL, Jacobson AM, Moses AC, Smith RJ, editors. Joslin’s diabetes mellitus, 14th ed. Boston: Lippincott Williams & Wilkins, 2005:823–37.Search in Google Scholar

5. Ford E. Body mass index, diabetes and C-reactive protein among U.S. adults. Diabetes Care 1999;22:1971–7.Search in Google Scholar

6. Hsia CC, Raskin P. The diabetic lung: relevance of alveolar microangiopathy for the use of inhaled insulin. Am J Med 2005;118:205–11.10.1016/j.amjmed.2004.09.019Search in Google Scholar

7. Sandler M. Is the lung a “target organ” in diabetes mellitus. Arch Intern Med 1990;150:1385–8.10.1001/archinte.1990.00390190051006Search in Google Scholar

8. Kuziemski K, Gorska L, Jassem E, Madej-Dmochowska A. Lung microangiopathy in diabetes. Pneumonol Alergol Pol 2009;77:394–9.10.5603/ARM.27794Search in Google Scholar

9. Schuyler MR, Niewoehner DE, Inkley SR, Kohn R. Abnormal lung elasticity in juvenile diabetes mellitus. Am Rev Respir Dis 1976;113:37–41.Search in Google Scholar

10. Schernthaner G, Haber P, Kummer R, Ludwig H. Lung elasticity in juvenile onset diabetes mellitus. Am Rev Respir Dis 1977;116:544–6.10.1164/arrd.1977.116.3.544Search in Google Scholar

11. Asanuma Y, Fujiya S, Ide H, Agishi Y. Characteristics of pulmonary function in patients with diabetes mellitus. Diabetes Res Clinical Pract 1985;1:95–101.10.1016/S0168-8227(85)80034-6Search in Google Scholar

12. Schnack C, Festa A, Schwarzmaier-D’Assie A, Haber P, Schernthaner G. Pulmonary dysfunction in type 1 diabetes in relation to metabolic long-term control and to incipient diabetic nephropathy. Nephron 1996;74:395–400.10.1159/000189342Search in Google Scholar PubMed

13. Benbassat CA, Stern E, Kramer M, Lebzelter J, Blum I, et al. Pulmonary function in patients with diabetes mellitus. Am J Med Sci 2001;322:127–32.10.1097/00000441-200109000-00003Search in Google Scholar PubMed

14. Buckingham B, Perejda AJ, Sandborg C, Kershnar AK, Uitto J. Skin, joint and pulmonary changes in type 1 diabetes mellitus. Am J Dis Child 1986;140:420–3.10.1001/archpedi.1986.02140190030018Search in Google Scholar PubMed

15. Primhak RA, Whincup G. Reduced vital capacity in insulin-dependent diabetes. Diabetes 1987;36:324–6.10.2337/diab.36.3.324Search in Google Scholar

16. Villa MP, Cacciari E, Bernardi F, Cicognani A, Salardi S, et al. Bronchial reactivity in diabetic patients. Relationship to duration of diabetes and degree of glycemic control. Am J Dis Child 1988;142:726–9.10.1001/archpedi.1988.02150070040021Search in Google Scholar

17. Verrotti A, Verini M, Chiarelli F, Verdesca V, Misticoni G, et al. Pulmonary function in diabetic children with and without persistent microalbuminuria. Diabetes Res Clin Pract 1993;21:171–6.10.1016/0168-8227(93)90066-ESearch in Google Scholar

18. Van Gent R, Brackel HJ, de Vroede M, Van der Ent CK. Lung function abnormalities in children with type 1 diabetes. Respir Med 2002;96:976–8.10.1053/rmed.2002.1402Search in Google Scholar

19. Villa M, Montesano M. Diffusing capacity for carbon monoxide in children with type 1 diabetes. Diabetologia 2004;47:1931–5.10.1007/s00125-004-1548-7Search in Google Scholar

20. Cazzato S, Bernardi F. Lung function in children with diabetes mellitus. Pediatr Pulmonol 2004;37:17–23.10.1002/ppul.10399Search in Google Scholar

21. Al-Saadi MM, Meo SA, Al-Drees AM, Mohamed S, Shaikh SA, et al. Lung functions in poorly controlled type 1 Saudi diabetic children and adolescents. Saudi Med J 2011;32:778–83.Search in Google Scholar

22. Lujbic S, Metelko Z, Car N, Roglic G, Drazic Z. Reduction of diffusion capacity for carbon monoxide in diabetic patients. Chest 1998;114:1033–5.10.1378/chest.114.4.1033Search in Google Scholar

23. Tanner JM. Growth at adolescence, 2nd ed. Oxford: Blackwell, 1962.Search in Google Scholar

24. ECSS. Report for working party on standardization of lung function tests. Eur Respir J 1993;6:16.Search in Google Scholar

25. Zapletal A, Samanek M, Paul T. Lung function in children and adolescents: methods, reference values. Karger: Basel, 1987.Search in Google Scholar

26. Stam H, Beek A, Grünberg K, Stijnen T, Tiddens HA, et al. Pulmonary diffusing capacity at reduced alveolar volumes in children. Pediatr Pulmonol 1996;21:84–9.10.1002/(SICI)1099-0496(199602)21:2<84::AID-PPUL4>3.0.CO;2-PSearch in Google Scholar

27. Rosenthal M, Bain SH, Cramer D, Helms P, Denison D, et al. Lung function in white children aged 4 to 19 years: I – Spirometry. Thorax 1993;48:794–802.10.1136/thx.48.8.794Search in Google Scholar

28. Rosenthal M, Cramer D, Bain SH, Denison D, Bush A, et al. Lung function in white children aged 4 to 19 years: II – Single breath analysis and plethysmography. Thorax 1993;48:803–8.10.1136/thx.48.8.803Search in Google Scholar

29. Weynand B, Jonckheere A, Frans A, Rahier J. Diabetes mellitus induces a thickening of pulmonary basal lamina. Respiration 1999;66:14–9.10.1159/000029331Search in Google Scholar PubMed

30. Schrader PC, Quanjer PH, van Zomeren BC, Wise ME. Changes in FEV1-height relationship during pubertal growth. Bull Eur Physiopathol Respir 1984;20:381–8.Search in Google Scholar

31. Wheatley CM, Baldi JC, Cassuto NA, Foxx-Lupo WT, Snyder EM. Glycemic control influences lung membrane diffusion and oxygen saturation in exercise-trained subjects with type 1 diabetes: alveolar-capillary membrane conductance in type 1 diabetes. Eur J Appl Physiol 2011;111:567–78.10.1007/s00421-010-1663-8Search in Google Scholar PubMed

Received: 2014-4-1
Accepted: 2014-7-14
Published Online: 2014-8-7
Published in Print: 2015-1-1

©2015 by De Gruyter

Articles in the same Issue

  1. Frontmatter
  2. Highlight: Childhood Craniopharyngioma
  3. Selected papers from the 3rd International Multidisciplinary Postgraduate Course, April 24–27, 2014
  4. Childhood craniopharyngioma – current status and recent perspectives in diagnostics and treatment
  5. The importance of interdisciplinary communication with patients about complex, chronic illnesses: our experiences as parents of a child with a craniopharyngioma
  6. Adamantinomatous craniopharyngioma: pathology, molecular genetics and mouse models
  7. Endocrine aspects and sequel in patients with craniopharyngioma
  8. Surgery for pediatric craniopharyngiomas: is less more?
  9. Eating behavior, weight problems and eating disorders in 101 long-term survivors of childhood-onset craniopharyngioma
  10. Carbohydrate-lipid profile and use of metformin with micronized fenofibrate in reducing metabolic consequences of craniopharyngioma treatment in children: single institution experience
  11. Effects of T3 treatment on brown adipose tissue and energy expenditure in a patient with craniopharyngioma and hypothalamic obesity
  12. Hypothalamic obesity after treatment for craniopharyngioma: the importance of the home environment
  13. Review article
  14. Association study of TAC3 and TACR3 gene polymorphisms with idiopathic precocious puberty in Chinese girls
  15. Images in pediatric endocrinology
  16. Intestinal invagination in diabetic ketoacidosis: case report
  17. Original articles
  18. Managing incidental findings and disclosure of results in a paediatric research cohort – the LIFE Child Study cohort
  19. The heterogeneity of hyperinsulinaemic hypoglycaemia in 19 patients with Beckwith-Wiedemann syndrome due to KvDMR1 hypomethylation
  20. Gender differences and age-related changes in body fat mass in Tibetan children and teenagers: an analysis by the bioelectrical impedance method
  21. A study of genes involved in adipocyte differentiation
  22. Initiation of growth hormone therapy in idiopathic short stature: do gender differences exist?
  23. The influence of puberty on vitamin D status in obese children and the possible relation between vitamin D deficiency and insulin resistance
  24. Growth failure associated with early neglect: pilot comparison of neglected US children and international adoptees
  25. Effect of growth hormone deficiency on brain MRI findings among children with growth restrictions
  26. Variability of lipid and lipoprotein concentrations during puberty in Brazilian boys
  27. Skin advanced glycation endproducts are elevated at onset of type 1 diabetes in youth
  28. Can optical coherence tomography predict early retinal microvascular pathology in type 1 diabetic adolescents without minimal diabetic retinopathy? A single-centre study
  29. Decreased levels of homoarginine and asymmetric dimethylarginine in children with type 1 diabetes: associations with cardiovascular risk factors but no effect by atorvastin
  30. Influence of catch-up growth on abdominal fat distribution in very low birth weight children – cohort study
  31. Thyrotoxic, hypokalemic periodic paralysis (THPP) in adolescents
  32. Pulmonary function in children with type 1 diabetes mellitus
  33. Identification of deletions in children with congenital hypothyroidism and thyroid dysgenesis with the use of multiplex ligation-dependent probe amplification
  34. Effect of l-thyroxine supplementation on infants with transient hypothyroxinemia of prematurity at 18 months of corrected age: randomized clinical trial
  35. Vitamin D-containing supplements for children between 1–3 years of age: Are they essential for bone health?
  36. Anti-Mullerian hormone levels in American girls by age and race/ethnicity
  37. The effect of tailoring of cornstarch intake on stature in children with glycogen storage disease type III
  38. Thyroid disease in Chinese girls with Turner syndrome
  39. Patient reports
  40. Pure gonadal dysgenesis (Swyer syndrome) due to microdeletion in the SRY gene: a case report
  41. Hypophosphatemic rickets caused by a novel splice donor site mutation and activation of two cryptic splice donor sites in the PHEX gene
  42. Novel heterozygous IGF1R mutation in two brothers with developing impaired glucose tolerance
  43. A case of pediatric ectopic thyroid in lateral lymph nodes
  44. Hyperostosis-hyperphosphatemia syndrome (HHS): report of two cases with a recurrent mutation and review of the literature
  45. Needle detachment from the Sure-T® infusion set in two young children with diabetes mellitus (DM) treated with continuous subcutaneous insulin infusion (CSII) and unexplained hyperglycaemia
  46. Familial dysalbuminemic hyperthyroxinemia in a 4-year-old girl with hyperactivity, palpitations and advanced dental age: how gold standard assays may be misleading
https://doi.org/10.1515/jpem-2014-0147
Keywords for this article
adolescent; children; pulmonary function; type 1 diabetes mellitus

Articles in the same Issue

  1. Frontmatter
  2. Highlight: Childhood Craniopharyngioma
  3. Selected papers from the 3rd International Multidisciplinary Postgraduate Course, April 24–27, 2014
  4. Childhood craniopharyngioma – current status and recent perspectives in diagnostics and treatment
  5. The importance of interdisciplinary communication with patients about complex, chronic illnesses: our experiences as parents of a child with a craniopharyngioma
  6. Adamantinomatous craniopharyngioma: pathology, molecular genetics and mouse models
  7. Endocrine aspects and sequel in patients with craniopharyngioma
  8. Surgery for pediatric craniopharyngiomas: is less more?
  9. Eating behavior, weight problems and eating disorders in 101 long-term survivors of childhood-onset craniopharyngioma
  10. Carbohydrate-lipid profile and use of metformin with micronized fenofibrate in reducing metabolic consequences of craniopharyngioma treatment in children: single institution experience
  11. Effects of T3 treatment on brown adipose tissue and energy expenditure in a patient with craniopharyngioma and hypothalamic obesity
  12. Hypothalamic obesity after treatment for craniopharyngioma: the importance of the home environment
  13. Review article
  14. Association study of TAC3 and TACR3 gene polymorphisms with idiopathic precocious puberty in Chinese girls
  15. Images in pediatric endocrinology
  16. Intestinal invagination in diabetic ketoacidosis: case report
  17. Original articles
  18. Managing incidental findings and disclosure of results in a paediatric research cohort – the LIFE Child Study cohort
  19. The heterogeneity of hyperinsulinaemic hypoglycaemia in 19 patients with Beckwith-Wiedemann syndrome due to KvDMR1 hypomethylation
  20. Gender differences and age-related changes in body fat mass in Tibetan children and teenagers: an analysis by the bioelectrical impedance method
  21. A study of genes involved in adipocyte differentiation
  22. Initiation of growth hormone therapy in idiopathic short stature: do gender differences exist?
  23. The influence of puberty on vitamin D status in obese children and the possible relation between vitamin D deficiency and insulin resistance
  24. Growth failure associated with early neglect: pilot comparison of neglected US children and international adoptees
  25. Effect of growth hormone deficiency on brain MRI findings among children with growth restrictions
  26. Variability of lipid and lipoprotein concentrations during puberty in Brazilian boys
  27. Skin advanced glycation endproducts are elevated at onset of type 1 diabetes in youth
  28. Can optical coherence tomography predict early retinal microvascular pathology in type 1 diabetic adolescents without minimal diabetic retinopathy? A single-centre study
  29. Decreased levels of homoarginine and asymmetric dimethylarginine in children with type 1 diabetes: associations with cardiovascular risk factors but no effect by atorvastin
  30. Influence of catch-up growth on abdominal fat distribution in very low birth weight children – cohort study
  31. Thyrotoxic, hypokalemic periodic paralysis (THPP) in adolescents
  32. Pulmonary function in children with type 1 diabetes mellitus
  33. Identification of deletions in children with congenital hypothyroidism and thyroid dysgenesis with the use of multiplex ligation-dependent probe amplification
  34. Effect of l-thyroxine supplementation on infants with transient hypothyroxinemia of prematurity at 18 months of corrected age: randomized clinical trial
  35. Vitamin D-containing supplements for children between 1–3 years of age: Are they essential for bone health?
  36. Anti-Mullerian hormone levels in American girls by age and race/ethnicity
  37. The effect of tailoring of cornstarch intake on stature in children with glycogen storage disease type III
  38. Thyroid disease in Chinese girls with Turner syndrome
  39. Patient reports
  40. Pure gonadal dysgenesis (Swyer syndrome) due to microdeletion in the SRY gene: a case report
  41. Hypophosphatemic rickets caused by a novel splice donor site mutation and activation of two cryptic splice donor sites in the PHEX gene
  42. Novel heterozygous IGF1R mutation in two brothers with developing impaired glucose tolerance
  43. A case of pediatric ectopic thyroid in lateral lymph nodes
  44. Hyperostosis-hyperphosphatemia syndrome (HHS): report of two cases with a recurrent mutation and review of the literature
  45. Needle detachment from the Sure-T® infusion set in two young children with diabetes mellitus (DM) treated with continuous subcutaneous insulin infusion (CSII) and unexplained hyperglycaemia
  46. Familial dysalbuminemic hyperthyroxinemia in a 4-year-old girl with hyperactivity, palpitations and advanced dental age: how gold standard assays may be misleading
Downloaded on 23.4.2026 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2014-0147/html
Scroll to top button